ijms-logo

Journal Browser

Journal Browser

RNA Modifications and Epitranscriptomics

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Macromolecules".

Deadline for manuscript submissions: closed (15 November 2022) | Viewed by 40082

Special Issue Editor


E-Mail Website
Guest Editor
Department and Institute of Pharmacology, National Yang-Ming University, Taipei 11217, Taiwan
Interests: RNA modification; epitranscriptome; disease; development; therapeutic strategies

Special Issue Information

Dear Colleagues,

In this Special Issue, we will highlight RNA modifications and epitranscriptomic regulation linked to development, disease, and biological functions. Specific chemical modifications on RNA have been proven to contribute an efficient method to finetune gene expression via post-transcription. Increasing evidence suggests that RNA-modifying enzymes can be potential drug targets in treating diseases such as cancer. In this issue, we aim to collect essential research papers and insightful review papers on the topics highlighted below:

  • RNA modification and disease
  • RNA modification and development
  • RNA modification regulators and their biological functions
  • Methodologies for RNA modifications mapping
  • Epitranscriptome
  • Epitranscriptic therapeutic strategies

Dr. Chianshiu Chien
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • RNA modification
  • epitranscriptome
  • disease
  • development
  • therapeutic strategies

Published Papers (3 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Review

15 pages, 1583 KiB  
Review
Post-Transcriptional Modification by Alternative Splicing and Pathogenic Splicing Variants in Cardiovascular Development and Congenital Heart Defects
by Zubin Mehta and Marlin Touma
Int. J. Mol. Sci. 2023, 24(2), 1555; https://doi.org/10.3390/ijms24021555 - 13 Jan 2023
Viewed by 2535
Abstract
Advancements in genomics, bioinformatics, and genome editing have uncovered new dimensions in gene regulation. Post-transcriptional modifications by the alternative splicing of mRNA transcripts are critical regulatory mechanisms of mammalian gene expression. In the heart, there is an expanding interest in elucidating the role [...] Read more.
Advancements in genomics, bioinformatics, and genome editing have uncovered new dimensions in gene regulation. Post-transcriptional modifications by the alternative splicing of mRNA transcripts are critical regulatory mechanisms of mammalian gene expression. In the heart, there is an expanding interest in elucidating the role of alternative splicing in transcriptome regulation. Substantial efforts were directed toward investigating this process in heart development and failure. However, few studies shed light on alternative splicing products and their dysregulation in congenital heart defects (CHDs). While elegant reports showed the crucial roles of RNA binding proteins (RBPs) in orchestrating splicing transitions during heart development and failure, the impact of RBPs dysregulation or genetic variation on CHDs has not been fully addressed. Herein, we review the current understanding of alternative splicing and RBPs’ roles in heart development and CHDs. Wediscuss the impact of perinatal splicing transition and its dysregulation in CHDs. We further summarize the discoveries made of causal splicing variants in key transcription factors that are implicated in CHDs. An improved understanding of the roles of alternative splicing in heart development and CHDs may potentially inform novel preventive and therapeutic advancements for newborn infants with CHDs. Full article
(This article belongs to the Special Issue RNA Modifications and Epitranscriptomics)
Show Figures

Figure 1

23 pages, 778 KiB  
Review
Epitranscriptome: Review of Top 25 Most-Studied RNA Modifications
by Viktoriia A. Arzumanian, Georgii V. Dolgalev, Ilya Y. Kurbatov, Olga I. Kiseleva and Ekaterina V. Poverennaya
Int. J. Mol. Sci. 2022, 23(22), 13851; https://doi.org/10.3390/ijms232213851 - 10 Nov 2022
Cited by 12 | Viewed by 2412
Abstract
The alphabet of building blocks for RNA molecules is much larger than the standard four nucleotides. The diversity is achieved by the post-transcriptional biochemical modification of these nucleotides into distinct chemical entities that are structurally and functionally different from their unmodified counterparts. Some [...] Read more.
The alphabet of building blocks for RNA molecules is much larger than the standard four nucleotides. The diversity is achieved by the post-transcriptional biochemical modification of these nucleotides into distinct chemical entities that are structurally and functionally different from their unmodified counterparts. Some of these modifications are constituent and critical for RNA functions, while others serve as dynamic markings to regulate the fate of specific RNA molecules. Together, these modifications form the epitranscriptome, an essential layer of cellular biochemistry. As of the time of writing this review, more than 300 distinct RNA modifications from all three life domains have been identified. However, only a few of the most well-established modifications are included in most reviews on this topic. To provide a complete overview of the current state of research on the epitranscriptome, we analyzed the extent of the available information for all known RNA modifications. We selected 25 modifications to describe in detail. Summarizing our findings, we describe the current status of research on most RNA modifications and identify further developments in this field. Full article
(This article belongs to the Special Issue RNA Modifications and Epitranscriptomics)
Show Figures

Graphical abstract

75 pages, 2482 KiB  
Review
Melatonin: Regulation of Viral Phase Separation and Epitranscriptomics in Post-Acute Sequelae of COVID-19
by Doris Loh and Russel J. Reiter
Int. J. Mol. Sci. 2022, 23(15), 8122; https://doi.org/10.3390/ijms23158122 - 23 Jul 2022
Cited by 5 | Viewed by 34609
Abstract
The relentless, protracted evolution of the SARS-CoV-2 virus imposes tremendous pressure on herd immunity and demands versatile adaptations by the human host genome to counter transcriptomic and epitranscriptomic alterations associated with a wide range of short- and long-term manifestations during acute infection and [...] Read more.
The relentless, protracted evolution of the SARS-CoV-2 virus imposes tremendous pressure on herd immunity and demands versatile adaptations by the human host genome to counter transcriptomic and epitranscriptomic alterations associated with a wide range of short- and long-term manifestations during acute infection and post-acute recovery, respectively. To promote viral replication during active infection and viral persistence, the SARS-CoV-2 envelope protein regulates host cell microenvironment including pH and ion concentrations to maintain a high oxidative environment that supports template switching, causing extensive mitochondrial damage and activation of pro-inflammatory cytokine signaling cascades. Oxidative stress and mitochondrial distress induce dynamic changes to both the host and viral RNA m6A methylome, and can trigger the derepression of long interspersed nuclear element 1 (LINE1), resulting in global hypomethylation, epigenetic changes, and genomic instability. The timely application of melatonin during early infection enhances host innate antiviral immune responses by preventing the formation of “viral factories” by nucleocapsid liquid-liquid phase separation that effectively blockades viral genome transcription and packaging, the disassembly of stress granules, and the sequestration of DEAD-box RNA helicases, including DDX3X, vital to immune signaling. Melatonin prevents membrane depolarization and protects cristae morphology to suppress glycolysis via antioxidant-dependent and -independent mechanisms. By restraining the derepression of LINE1 via multifaceted strategies, and maintaining the balance in m6A RNA modifications, melatonin could be the quintessential ancient molecule that significantly influences the outcome of the constant struggle between virus and host to gain transcriptomic and epitranscriptomic dominance over the host genome during acute infection and PASC. Full article
(This article belongs to the Special Issue RNA Modifications and Epitranscriptomics)
Show Figures

Figure 1

Back to TopTop